{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:29:16Z","timestamp":1793964556324,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":91,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.100939","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:05:40Z","timestamp":1779282340000},"page":"100939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Age trumps metabolism: No independent association between lipids, statins, and prostate enlargement in a metabolically controlled cohort"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3401-4964","authenticated-orcid":false,"given":"Lucas Neves de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-1983","authenticated-orcid":false,"given":"Ricardo Brianezi","family":"Tiraboschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5321-3796","authenticated-orcid":false,"given":"Caroline Santos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-9666","authenticated-orcid":false,"given":"Jair Bomfim","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2777-989X","authenticated-orcid":false,"given":"Mateus Neves de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-4003","authenticated-orcid":false,"given":"Cristiano Mendes","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-4889","authenticated-orcid":false,"given":"Jose","family":"Bessa Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clinsp.2026.100939_bib0001","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/iju.15518","article-title":"Chronic inflammation in benign prostatic hyperplasia: pathophysiology and treatment options","volume":"31","author":"Inamura","year":"2024","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.clinsp.2026.100939_bib0002","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/nau.23446","article-title":"The prevalence of lower urinary tract symptoms (LUTS) in Brazil: results from the epidemiology of LUTS (Brazil LUTS) study","volume":"37","author":"Soler","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100939_bib0003","first-page":"64","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Mil Med Res"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100939_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2010.07.515","article-title":"Effect of a hypercholesterolemic diet on serum lipid profile, plasma sex steroid levels, and prostate structure in rats","volume":"76","author":"Ploumidou","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100939_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-5347(05)00041-8","article-title":"Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater","volume":"175","author":"Kaplan","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100939_bib0006","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.urology.2014.03.007","article-title":"Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia","volume":"83","author":"Vanella","year":"2014","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0007","first-page":"198","article-title":"The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study","volume":"20","author":"Besiroglu","year":"2017","journal-title":"Aging Male"},{"issue":"6","key":"10.1016\/j.clinsp.2026.100939_bib0008","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.urology.2006.09.034","article-title":"Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans","volume":"68","author":"Gupta","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0009","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","article-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","volume":"101","author":"Parsons","year":"2008","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajur.2017.05.001","article-title":"Metabolic syndrome and benign prostatic hyperplasia: an update","volume":"4","author":"Ngai","year":"2017","journal-title":"Asian J Urol"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0019-5154.182410","article-title":"Methodology series Module 3: cross-sectional studies","volume":"61","author":"Setia","year":"2016","journal-title":"Indian J Dermatol"},{"issue":"19","key":"10.1016\/j.clinsp.2026.100939_bib0012","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinsp.2026.100939_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211066210","article-title":"Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors","volume":"12","author":"Omran","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","article-title":"Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia","volume":"1","author":"Hammarsten","year":"1998","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100939_bib0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bju.13334","article-title":"Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study","volume":"117","author":"DiBello","year":"2016","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100939_bib0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pros.23451","article-title":"Hyperlipidemia is associated with an increased risk of clinical benign prostatic hyperplasia","volume":"78","author":"Shih","year":"2018","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.clinsp.2026.100939_bib0017","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.3390\/ijms24054911","article-title":"Simvastatin improves benign prostatic hyperplasia: role of peroxisome-proliferator-activated receptor-\u03b3 and classic WNT\/\u03b2-catenin pathway","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100939_bib0018","doi-asserted-by":"crossref","first-page":"116","DOI":"10.18632\/aging.206187","article-title":"The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in patients with benign prostatic hyperplasia in relation to metabolic syndrome","volume":"17","author":"Ratajczak","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clinsp.2026.100939_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123192","article-title":"Association between metabolic syndrome and benign prostatic hyperplasia: the underlying molecular connection","volume":"358","author":"Fu","year":"2024","journal-title":"Life Sci"},{"issue":"14","key":"10.1016\/j.clinsp.2026.100939_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411634","article-title":"Mechanism of androgen-independent stromal proliferation in benign prostatic hyperplasia","volume":"24","author":"Hata","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.clinsp.2026.100939_bib0021","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/ijms24032870","article-title":"The emerging role of cell adhesion molecules on benign prostatic hyperplasia","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100939_bib0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/diseases13020053","article-title":"Oxidative stress in benign prostatic hyperplasia: mechanisms, clinical relevance and therapeutic perspectives","volume":"13","author":"Kaltsas","year":"2025","journal-title":"Diseases"},{"issue":"12","key":"10.1016\/j.clinsp.2026.100939_bib0023","doi-asserted-by":"crossref","first-page":"7840","DOI":"10.1097\/JS9.0000000000001557","article-title":"Epidemiological investigation of sex hormones and their metabolism-related gene single nucleotide polymorphisms in patients with benign prostatic hyperplasia complicated with late-onset hypogonadism: a retrospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.clinsp.2026.100939_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306860","article-title":"The relationship between complete blood cell count-derived inflammatory biomarkers and benign prostatic hyperplasia in middle-aged and elderly individuals in the United States: evidence from NHANES 2001-2008","volume":"19","author":"Shi","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100939_bib0025","doi-asserted-by":"crossref","first-page":"869","DOI":"10.21037\/tau-20-1320","article-title":"Prostatic artery embolization: magnetic resonance image (MRI) findings in the early detection of prostate infarction in a canine spontaneous benign prostatic hyperplasia model","volume":"10","author":"Lucas-Cava","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"2","key":"10.1016\/j.clinsp.2026.100939_bib0026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5213\/inj.2346028.014","article-title":"Role of pelvic ischemia in Human lower urinary tract symptoms and sexual function among patients with common Iliac artery obstruction undergoing revascularization surgery","volume":"27","author":"Papaefstathiou","year":"2023","journal-title":"Int Neurourol J"},{"issue":"12","key":"10.1016\/j.clinsp.2026.100939_bib0027","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.21037\/tau-22-423","article-title":"Prostatic artery occlusion: initial findings on pathophysiological response in a canine prostate model","volume":"11","author":"Lucas-Cava","year":"2022","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100939_bib0028","doi-asserted-by":"crossref","first-page":"384","DOI":"10.21037\/tau-20-1127","article-title":"The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching","volume":"10","author":"Xiong","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.clinsp.2026.100939_bib0029","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1038\/s41598-022-10904-7","article-title":"Association between life-style, metabolic syndrome and lower urinary tract symptoms and its impact on quality of life in men \u2009\u2265 40-years","volume":"12","author":"Jeong","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinsp.2026.100939_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urology.2021.09.006","article-title":"Effect of metabolic syndrome on anatomy and function of the lower urinary tract assessed on MRI","volume":"159","author":"Tannenbaum","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.clinsp.2026.100939_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.554078","article-title":"Endocrinology of the aging prostate: current concepts","volume":"12","author":"Cannarella","year":"2021","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593226000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:17:21Z","timestamp":1793963841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593226000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S1807593226000803"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100939","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age trumps metabolism: No independent association between lipids, statins, and prostate enlargement in a metabolically controlled cohort","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.100939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of HCFMUSP.","name":"copyright","label":"Copyright"}],"article-number":"100939"}}